Distinct roles of VEGFR-1 and VEGFR-2 in the aberrant hematopoiesis associated with elevated levels of VEGF. - Wikidata - wikimedia - TriplyDB

Distinct roles of VEGFR-1 and VEGFR-2 in the aberrant hematopoiesis associated with elevated levels of VEGF.

Distinct roles of VEGFR-1 and VEGFR-2 in the aberrant hematopoiesis associated with elevated levels of VEGF.

http://www.wikidata.org/entity/Q35900957

about

Inhibition of Immune Checkpoints and Vascular Endothelial Growth Factor as Combination Therapy for Metastatic Melanoma: An Overview of Rationale, Preclinical Evidence, and Initial Clinical Data Vascular normalization and cancer immunotherapy Control of the immune response by pro-angiogenic factors Attenuated transforming growth factor beta signaling promotes metastasis in a model of HER2 mammary carcinogenesis Cytokine levels correlate with immune cell infiltration after anti-VEGF therapy in preclinical mouse models of breast cancer.Severe pulmonary arterial hypertension induced by SU5416 and ovalbumin immunization.Angiogenic Factors Correlate with T Cell Immune Reconstitution and Clinical Outcomes after Double-Unit Umbilical Cord Blood Transplantation in Adults.Rgs2 mediates pro-angiogenic function of myeloid derived suppressor cells in the tumor microenvironment via upregulation of MCP-1.Context- and cell-dependent effects of Delta-like 4 targeting in the bone marrow microenvironment.Chronic psychological stress induces the accumulation of myeloid-derived suppressor cells in mice.VEGF-A modulates expression of inhibitory checkpoints on CD8+ T cells in tumors.Resuscitating cancer immunosurveillance: selective stimulation of DLL1-Notch signaling in T cells rescues T-cell function and inhibits tumor growth.Axitinib increases the infiltration of immune cells and reduces the suppressive capacity of monocytic MDSCs in an intracranial mouse melanoma model.Absolute lymphocyte count is associated with survival in ovarian cancer independent of tumor-infiltrating lymphocytes Plumbagin inhibits tumour angiogenesis and tumour growth through the Ras signalling pathway following activation of the VEGF receptor-2 CD4+VEGFR1(HIGH) T cell as a novel Treg subset regulates inflammatory bowel disease in lymphopenic mice Association of single nucleotide polymorphisms in IL8 and IL13 with sunitinib-induced toxicity in patients with metastatic renal cell carcinoma.Multivalent Forms of the Notch Ligand DLL-1 Enhance Antitumor T-cell Immunity in Lung Cancer and Improve Efficacy of EGFR-Targeted Therapy.Vascular normalizing doses of antiangiogenic treatment reprogram the immunosuppressive tumor microenvironment and enhance immunotherapy Tumor-derived granulocyte-macrophage colony-stimulating factor regulates myeloid inflammation and T cell immunity in pancreatic cancer.Understanding lymphangiogenesis in knockout models, the cornea, and ocular diseases for the development of therapeutic interventions.Host A(2B) adenosine receptors promote carcinoma growth Vascular normalization as an emerging strategy to enhance cancer immunotherapy.VEGF-mediated cross-talk within the neonatal murine thymus.VEGF and pleiotrophin modulate the immune profile of breast cancer.Immunological off-target effects of standard treatments in gastrointestinal cancers Cancer-associated myeloproliferation: old association, new therapeutic target.Small-molecule protein kinase inhibitors and their effects on the immune system: implications for cancer treatment.Hematopoietic cytokine-induced transcriptional regulation and Notch signaling as modulators of MDSC expansion.Myeloid-derived suppressor cells in transplantation and cancer Negative regulation of myeloid-derived suppressor cells in cancer.Modulation of immunity by antiangiogenic molecules in cancer.Review of angiogenesis in hepatocellular carcinoma.Myeloid-derived suppressor cells in B cell malignancies.Rationally combining anti-VEGF therapy with checkpoint inhibitors in hepatocellular carcinoma.Plumbagin and Its Role in Chronic Diseases.Barriers to Radiation-Induced In Situ Tumor Vaccination.From top to bottom: midkine and pleiotrophin as emerging players in immune regulation.Myeloid-derived suppressor cell and macrophage exert distinct angiogenic and immunosuppressive effects in breast cancer.The immunosuppressive factors IL-10, TGF-β, and VEGF do not affect the antigen-presenting function of CD40-activated B cells.

P2860

Q26781098-F7CA4C88-30D9-44E1-B03A-54EB3CB9CFDA Q26827437-DB6731F0-D4FB-4D31-859C-2251A31E50B5 Q27004733-638CB1B8-2B9D-4B5A-8D95-EF9EEBFC2288 Q28386225-C4236D8C-2C82-493D-8775-BC4FF2FE0A6F Q33514852-8BAC4FBC-37B6-4B4D-A65C-E7E07A83FA44 Q33764990-FD937F80-686B-495A-928A-99A491EAE96B Q33847973-EFD04AF8-3215-454D-9CB1-2B72681C684C Q33873408-C8D69EE4-4B5B-4EB1-A696-3314454FB669 Q34533929-74E697C4-92E4-42CA-985E-8CB54C1A7C18 Q34994724-04CA2D97-A28D-4493-B8EA-F5D9D91F615C Q35064894-FDABCA17-ABDA-48BF-B344-C59F3EEE26FA Q35256189-D1E86BBA-ACD1-4593-990F-99B50DF7A341 Q35798966-48647E55-B435-45A2-B5DB-D6C858DF1A7B Q35847903-911985D3-BCEB-442E-A0FF-F24CC6118F4A Q35940368-3E6EEF1A-165D-4816-9CD3-C29E4308A5D3 Q36085110-962D092D-7921-4B5E-A8F4-F98D66EFC52B Q36275134-0FE3FC00-4E0C-4BE5-A319-AE4B985281B1 Q36296504-F8F73BEF-3AE6-4694-A3BC-2FE0C4162018 Q36378276-C61C7B89-09D9-41ED-AF2E-5519BA37EABE Q36617328-B7BE58C9-A4B6-4949-9C72-C68CABBEF88F Q36808641-4744D74C-2E8A-40C8-B350-A8B58909C340 Q36840284-DAB8963F-0933-4C08-A5E3-17C1FF23450A Q36847357-64B13F51-9845-49A8-870D-864405F6C2EA Q37142168-4B2D3CB3-DCEC-45B9-8696-9532F53554D9 Q37328378-D74C9BA3-E0B4-4925-A06A-FFE22977B423 Q37404086-15576617-41F0-4761-A84B-7B6DEA27CD76 Q37769017-C2D864CC-B2BD-41ED-A421-B1B2F79611C1 Q37842326-AEE93F70-0142-49E9-A796-3329252498AD Q37856017-ECCF410D-FE39-4D41-AF6C-8230229380C3 Q38005601-DDA15816-F739-4B4D-BE53-8E2C3521847C Q38047048-8CB80DF3-D794-49FD-9FF8-D5EC2A203622 Q38074154-721F9808-70E1-41BA-954C-7DCE65A88B7F Q38188582-B516CBDD-2172-43DC-8940-7D2194049D42 Q38578686-355D40A0-F52E-407D-9292-F4B293FBB479 Q38728953-A9D3EC45-05C8-44B4-AD32-7CE73563971F Q38988584-49AC5D17-6D26-4422-AC0A-B69A7F237CF6 Q39203685-0512F757-E957-4979-85C9-BA74B9C01E93 Q39207404-4CE6A56C-1824-4C77-8F50-8D1543D50708 Q41552935-B2C8AEDB-5F1E-46B7-A484-A0F4810D35FD Q41761209-BA0CA527-3A44-49B0-B464-3AA950C2B028

P2860

Distinct roles of VEGFR-1 and VEGFR-2 in the aberrant hematopoiesis associated with elevated levels of VEGF.

http://www.wikidata.org/entity/Q35900957

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Distinct roles of VEGFR-1 and ...... with elevated levels of VEGF.

@ast

Distinct roles of VEGFR-1 and ...... with elevated levels of VEGF.

@en

type

label

Distinct roles of VEGFR-1 and ...... with elevated levels of VEGF.

@ast

Distinct roles of VEGFR-1 and ...... with elevated levels of VEGF.

@en

prefLabel

Distinct roles of VEGFR-1 and ...... with elevated levels of VEGF.

@ast

Distinct roles of VEGFR-1 and ...... with elevated levels of VEGF.

@en

P1433

Q35900957-524257FD-CA5D-4CB2-8860-D2E49C8A33ED

P1476

Q35900957-39E081CE-8626-4C9A-89E9-202CBE704C35

P2093

Q35900957-2EA5801D-1369-4479-A3A4-46D3C63F8EA0

Q35900957-37F5F7AF-9AF0-4A6F-862E-6AD0C4D4089F

Q35900957-55D2CC97-2613-42CF-876E-BB329DA3405A

Q35900957-83014EA8-ECE7-4AC9-B16E-A6D188A653E5

Q35900957-8344D07E-EC96-455F-9155-F3AC60EA187D

Q35900957-D5D41E6D-210E-4CD6-A9B0-45B3F9FA37B8

Q35900957-DB7D6743-37B5-41A9-8B5D-33DE80589C24

P2860

Q35900957-07D79944-E3A7-4D5F-9B80-260DE5C70429

Q35900957-1CBA5A47-606C-4E4A-A4BB-B33C8FB37493

Q35900957-1F132413-60B0-49A1-9169-DB2A05A16FEA

Q35900957-2B9F7C0A-DC0E-40C3-8630-BF0B4433EDFE

Q35900957-34F7F9D0-EA5C-40BC-92F1-585AAEEEDCDC

Q35900957-3BE40F8A-4ED1-4A3D-AD68-16AE6B13A18A

Q35900957-3D023B4B-B3B4-4A3D-84C8-30D0B0D5E2CD

Q35900957-435F14D9-F9B0-4DB8-9987-C02DA893407D

Q35900957-4A3CE549-61EE-4CA8-ABA4-8618132FF95C

Q35900957-51E21A15-DAF6-4BA3-AC34-EC9C51C35D98

P304

Q35900957-6737FFCA-97C3-4ED7-9502-B34176F0F8D7

P31

Q35900957-4612AFA7-6963-4A7C-B821-6C57480D9117

P356

Q35900957-1A9D1BA2-BB48-4CE9-8A78-CBD5021AE563

P407

Q35900957-97CDE93E-D0B8-4C53-88F7-ACE9F93821DF

P433

Q35900957-AE369D77-6C89-4719-AC83-A0FD355AA0DB

P478

Q35900957-BBA85F64-113D-4A4C-B974-E7CDA1E1B2B9

P577

Q35900957-42F15301-2E27-4E19-9721-522A75DA3E6F

P5875

Q35900957-37A9AC7B-043D-4856-88D0-3F9C28EA0395

P698

Q35900957-B4059940-8CC3-4B8E-84AE-DD62D1A33692

P921

Q35900957-2AE16A0D-B411-4CC7-91B8-716D70F03E5A

P932

Q35900957-D8077970-3538-4D67-8BEE-52799AC904BA

P356

BLOOD-2007-01-065714

P1433

P1476

Distinct roles of VEGFR-1 and ...... with elevated levels of VEGF.

@en

P2093

Claudio A Mosse

http://www.w3.org/2001/XMLSchema#string

David P Carbone

http://www.w3.org/2001/XMLSchema#string

Li Yang

http://www.w3.org/2001/XMLSchema#string

Mikhail M Dikov

http://www.w3.org/2001/XMLSchema#string

Sergey V Novitskiy

http://www.w3.org/2001/XMLSchema#string

Xiaolan Chen

http://www.w3.org/2001/XMLSchema#string

Yuhui Huang

http://www.w3.org/2001/XMLSchema#string

P2860

VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche

The biology of VEGF and its receptors

Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth

Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium

Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice

Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene

Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele

Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis

Adult bone marrow-derived cells recruited during angiogenesis comprise precursors for periendothelial vascular mural cells.

Monoclonal antibodies targeting the VEGF receptor-2 (Flk1/KDR) as an anti-angiogenic therapeutic strategy.

P304

624-631

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2007-01-065714

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

110

http://www.w3.org/2001/XMLSchema#string

P577

2007-03-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6430186

http://www.w3.org/2001/XMLSchema#string

P698

17376891

http://www.w3.org/2001/XMLSchema#string

P921

P932

1924481

http://www.w3.org/2001/XMLSchema#string